Novel pyrrolidinone derivative lacks claimed histamine H3 receptor stimulation in receptor binding and functional studies.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2020.112150
Abstract: Since the discovery and early characterization of the histamine H3 receptor (H3R) in the 1980's, predominantly imidazole-based agonists were presented to the scientific community such as Nα-methylhistamine (Nα-MeHA) or (R)-α-methylhistamine ((R)α-MeHA). Whereas therapeutic applications have… read more here.
Keywords: novel pyrrolidinone; lacks claimed; pyrrolidinone derivative; derivative lacks ... See more keywords